Patients With Rheumatic Diseases Need to Be Monitored for HBV Reactivation

Clinicians need to monitor reactivation of the hepatitis B virus in patients with rheumatic diseases by testing for elevation of liver enzymes and HBV DNA ...

Temporary Methotrexate Discontinuation in RA: Ensuring Vaccination Immunogenicity

Rheumatologists should coordinate with the patient's primary care provider to facilitate an effective and comprehensive vaccination schedule.

Expert Q&A: Effects of Collaborative Care Models on Patient Satisfaction in Rheumatoid Arthritis

John M. Davis III, MD, MS, from the Mayo Clinic in Rochester, Minnesota, and Jennifer Gorman, MD, MPH, from The Polyclinic in Seattle, Washington, discuss ...

Chikungunya Virus: What Every Rheumatologist Should Know

Chikungunya virus has become a disease of global concern due to its potentially disabling consequences and its efficient transmission.

Pregnancy in Rheumatic Disease: Managing Potentially Teratogenic Medications

Petros Efthimiou, MD, a rheumatologist at NYU Langone Health, discusses how clinicians should approach prescribing potentially teratogenic drugs in pregnancy.

Comparing Tumor Necrosis Factor Inhibitors for RA and SpA: Overview & Expert Interview

They similarities and differences of anti-TNF drug function in RA and SpA are discussed in an expert interview.

Choosing the Right TNF Inhibitor Therapy for Rheumatoid Arthritis

There are important differences in TNFis for specific clinical conditions that recent research has made more apparent.

Improving Function Through Exercise in Rheumatoid Arthritis

Although recent pharmacologic advances have improved disease progression and prognosis in RA, a number of patients experience joint stiffness.

Pregnancy in Inflammatory Arthritis: What Your Patients Need to Know

Megan Clowse, MD, MPH, discusses 2 studies that examine reproductive health concerns in women with inflammatory rheumatic diseases.

Infection in Rheumatoid Arthritis and Antigen-Specific Immunotherapy

Continued research is needed to guide a clearer understanding of the role infectious agents, anticitrullinated protein antibodies, and antinative protein antibodies play in rheumatoid arthritis ...

Latest News

False-Positive Tuberculin Skin Test Results Linked to Methotrexate Therapy

False-Positive Tuberculin Skin Test Results Linked to Methotrexate Therapy

High rates of false-positive results on the tuberculin skin test have been reported among patients treated with methotrexate.

RA Treatment During Pregnancy: Is Infection Risk Greater in Offspring?

RA Treatment During Pregnancy: Is Infection Risk Greater in Offspring?

Children exposed to TNFi's during the gestational period were found not to have a significantly higher risk of developing serious infections.

HBV Status Linked to Disease Activity and Progression in Rheumatoid Arthritis

HBV Status Linked to Disease Activity and Progression in Rheumatoid Arthritis

Patients with rheumatoid arthritis with chronic hepatitis B virus infection demonstrated greater radiographic progression and poorer clinical response at 1 year.

Risks Associated With Co-Administration of Aspirin and Other NSAIDs

Risks Associated With Co-Administration of Aspirin and Other NSAIDs

In patients with rheumatoid arthritis or osteoarthritis who are at higher risk for cardiovascular events, celecoxib may be safer compared with naproxen or ibuprofen when these drugs are taken alone or in combination with aspirin.

Corticosteroid-Related Adverse Events Examined Based on Dose, Duration

Corticosteroid-Related Adverse Events Examined Based on Dose, Duration

Using a privately-insured administrative database, researchers examined a total of 78,704 patients with autoimmune or inflammatory disease diagnoses between 2006 and 2015.

RA: Low Probability of Achieving LDA With Lack of Early Response to Tofacitinib

RA: Low Probability of Achieving LDA With Lack of Early Response to Tofacitinib

This study sought to examine the link between early disease activity changes and attainment of LDA and remission targets in tofacitinib-treated patients with RA.

Decreased Muscle Performance Linked to Increased Disease Activity in Rheumatoid Arthritis

Decreased Muscle Performance Linked to Increased Disease Activity in Rheumatoid Arthritis

Poorer muscle performance composite scores are associated with increased Disease Activity Scores for 28 joints in patients with rheumatoid arthritis.

Effects of Certolizumab Pegol Exposure on Pregnancy Outcomes in Women With Rheumatic Disease

Effects of Certolizumab Pegol Exposure on Pregnancy Outcomes in Women With Rheumatic Disease

Researchers sought to provide information on pregnancy outcomes, including major congenital malformations and other maternal and fetal adverse outcomes, in women treated with certolizumab pegol.

FDA Advisory Committee Recommends Against Approval of Baricitinib at Higher Dose for RA

FDA Advisory Committee Recommends Against Approval of Baricitinib at Higher Dose for RA

The FDA advisory panel voted in favor of baricitinib for the treatment of rheumatoid arthritis, but only recommended approval of the 2 mg dose.

GI Safety Compared for NSAIDs in Patients With Arthritis

GI Safety Compared for NSAIDs in Patients With Arthritis

The randomized, double-blind, controlled trial (N=24,081) included patients with rheumatoid arthritis or osteoarthritis who required chronic NSAID treatment.

Latest Slideshows

Alcohol Use: Surveying Effects on the Body's Major Systems

Alcohol Use: Surveying Effects on the Body's Major Systems

The effects of alcohol on the body's systems are examined here, with both damaging and potentially protective effects being explored. ...

Ten Unusually Specific ICD-10 Codes

Ten Unusually Specific ICD-10 Codes

With nearly 70,000 ICD-10 diagnosis codes available to clinicians, things are bound to get interesting.

Role of Vitamin D in Rheumatoid Arthritis Pathogenesis

Role of Vitamin D in Rheumatoid Arthritis Pathogenesis

Increasing evidence indicates serum vitamin D levels and polymorphisms in enzymes involved in vitamin D metabolism can affect the risk ...

Mitigating Risk of Cardiovascular Disease in Rheumatoid Arthritis

Mitigating Risk of Cardiovascular Disease in Rheumatoid Arthritis

Patients with rheumatoid arthritis have an increased risk of developing cardiovascular disease (CVD) and CVD-related mortality compared with the general ...

Examining Patient-Reported Outcomes in Rheumatoid Arthritis

Examining Patient-Reported Outcomes in Rheumatoid Arthritis

Validation of a patient-report outcome instrument as an effective independent tool for measuring disease activity and treatment response may one ...

Sign Up for Free e-newsletters